Jason Amello - 28 Nov 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Financial Officer
Signature
/s/ Jason Amello
Issuer symbol
CADL
Transactions as of
28 Nov 2023
Net transactions value
-$18,138
Form type
4
Filing time
30 Nov 2023, 17:00:11 UTC
Previous filing
28 Nov 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Tax liability $18,138 -20,153 -9.1% $0.9000 202,009 28 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units.